SI9300443A - Substituted benzylamino nitrogen containing non-aromatic heterocycles - Google Patents
Substituted benzylamino nitrogen containing non-aromatic heterocycles Download PDFInfo
- Publication number
- SI9300443A SI9300443A SI9300443A SI9300443A SI9300443A SI 9300443 A SI9300443 A SI 9300443A SI 9300443 A SI9300443 A SI 9300443A SI 9300443 A SI9300443 A SI 9300443A SI 9300443 A SI9300443 A SI 9300443A
- Authority
- SI
- Slovenia
- Prior art keywords
- alkyl
- amino
- phenyl
- methyl
- methoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93239292A | 1992-08-19 | 1992-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9300443A true SI9300443A (en) | 1994-06-30 |
Family
ID=25462237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9300443A SI9300443A (en) | 1992-08-19 | 1993-08-23 | Substituted benzylamino nitrogen containing non-aromatic heterocycles |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5721255A (de) |
| EP (2) | EP0655996B1 (de) |
| JP (1) | JP2909214B2 (de) |
| CN (1) | CN1088917A (de) |
| AT (1) | ATE208376T1 (de) |
| AU (1) | AU4224993A (de) |
| CA (1) | CA2141048C (de) |
| DE (1) | DE69331103T2 (de) |
| DK (1) | DK0655996T3 (de) |
| ES (1) | ES2164072T3 (de) |
| FI (1) | FI106552B (de) |
| HU (1) | HU9302372D0 (de) |
| IL (1) | IL106670A0 (de) |
| MX (1) | MX9304996A (de) |
| PT (1) | PT655996E (de) |
| SI (1) | SI9300443A (de) |
| WO (1) | WO1994004496A1 (de) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2087813B1 (es) * | 1993-08-09 | 1997-02-01 | Pfizer | Heterociclos no-aromaticos que contienen nitrogeno bencilamino substituidos. |
| GB9317987D0 (en) * | 1993-08-26 | 1993-10-13 | Glaxo Group Ltd | Chemical compounds |
| EP0719266A1 (de) * | 1993-09-17 | 1996-07-03 | Pfizer Inc. | Durch heteroarylamino und heteroarylsulfonamido substituierte 3-benzylaminomethyl piperidine und verwandte derivate |
| EP0653208A3 (de) * | 1993-11-17 | 1995-10-11 | Pfizer | Substanz P Antagonisten zur Behandlung oder Verhütung des sonnenbrandes. |
| EP0659409A3 (de) * | 1993-11-23 | 1995-08-09 | Pfizer | Substanz P Antagonisten zur Hemmung der Angiogenese. |
| EP0655246A1 (de) * | 1993-11-30 | 1995-05-31 | Pfizer Inc. | Substanz P Antagonisten zur Behandlung von durch Helicobacter Pylori oder andere spirale Urease-positive Gram-negative Bakterien verursachten Krankheiten |
| IL116249A (en) * | 1994-12-12 | 2003-07-06 | Pfizer | Nk-1 receptor antagonists for the treatment of neuronal damage and stroke |
| TW458774B (en) | 1995-10-20 | 2001-10-11 | Pfizer | Antiemetic pharmaceutical compositions |
| GB9525296D0 (en) * | 1995-12-11 | 1996-02-07 | Merck Sharp & Dohme | Therapeutic agents |
| DK0780375T3 (da) * | 1995-12-21 | 2002-10-07 | Pfizer | 3-((5-substitueret benzyl)amino)-2-phenylpiperidiner som substans P-antagonister |
| MX9706196A (es) * | 1996-08-14 | 1998-02-28 | Pfizer | Compuestos triciclicos de piperidinilamino como antagonistas de la sustancia p. |
| EP0991622A1 (de) * | 1997-06-27 | 2000-04-12 | MERCK SHARP & DOHME LTD. | Substituierte 3-(benzylamino)piperidin derivate und ihre verwendung als therapeutische wirkstoffe |
| WO2002022579A2 (en) * | 2000-09-11 | 2002-03-21 | Sepracor, Inc. | Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| WO2002028853A1 (fr) * | 2000-10-02 | 2002-04-11 | Tanabe Seiyaku Co., Ltd. | Compose de benzylamine, son procede de production et produit intermediaire correspondant |
| DE10155075A1 (de) | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Cyclische Sulfonamide |
| US6861526B2 (en) | 2002-10-16 | 2005-03-01 | Pfizer Inc. | Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine |
| WO2005045395A2 (en) * | 2003-10-27 | 2005-05-19 | Meyer Donald W | Method of detecting bovine spongiform encephalopathy |
| KR101412339B1 (ko) | 2004-07-15 | 2014-06-25 | 알바니 몰레큘라 리써치, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를차단하기 위한 용도 |
| US8362075B2 (en) | 2005-05-17 | 2013-01-29 | Merck Sharp & Dohme Corp. | Cyclohexyl sulphones for treatment of cancer |
| EP2886549A1 (de) * | 2005-07-04 | 2015-06-24 | Zannan Scitech Co., Ltd. | Rutheniumkomplexligand, Rutheniumkomplex erwendung des Komplexes als Katalysator in Olefinmetathesereaktionen |
| US7956050B2 (en) | 2005-07-15 | 2011-06-07 | Albany Molecular Research, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| EP1940842B1 (de) | 2005-09-29 | 2012-05-30 | Merck Sharp & Dohme Corp. | Acylierte spiropiperidinderivate als modulatoren des melanocortin-4-rezeptors |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| WO2008039327A2 (en) | 2006-09-22 | 2008-04-03 | Merck & Co., Inc. | Method of treatment using fatty acid synthesis inhibitors |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| PL2336120T3 (pl) | 2007-01-10 | 2014-12-31 | Msd Italia Srl | Kombinacje zawierające indazole podstawione grupą amidową jako inhibitory polimerazy poli(ADP-rybozy) (PARP) |
| US8106086B2 (en) | 2007-04-02 | 2012-01-31 | Msd K.K. | Indoledione derivative |
| CA2690191C (en) | 2007-06-27 | 2015-07-28 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| WO2009111354A2 (en) | 2008-03-03 | 2009-09-11 | Tiger Pharmatech | Tyrosine kinase inhibitors |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815784D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815781D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| TW201026675A (en) * | 2008-10-09 | 2010-07-16 | Anadys Pharmaceuticals Inc | 5,6-dihydro-1H-pyridin-2-one compounds |
| WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| KR101830447B1 (ko) | 2009-05-12 | 2018-02-20 | 알바니 몰레큘라 리써치, 인크. | 7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도 |
| US9034899B2 (en) | 2009-05-12 | 2015-05-19 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| WO2010132487A1 (en) | 2009-05-12 | 2010-11-18 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
| PE20121172A1 (es) | 2009-10-14 | 2012-09-05 | Merck Sharp & Dohme | Piperidinas sustituidas con actividad en la hdm2 |
| US8999957B2 (en) | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
| CA2805265A1 (en) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina) |
| CA2807307C (en) | 2010-08-17 | 2021-02-09 | Merck Sharp & Dohme Corp. | Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
| EP2608669B1 (de) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer |
| US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
| EP2632472B1 (de) | 2010-10-29 | 2017-12-13 | Sirna Therapeutics, Inc. | Durch rna-interferenz vermittelte inhibition einer genexpression unter verwendung von short-interfering-nukleinsäuren (sina) |
| US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| IN2013MN02170A (de) | 2011-04-21 | 2015-06-12 | Piramal Entpr Ltd | |
| WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| EP2844261B1 (de) | 2012-05-02 | 2018-10-17 | Sirna Therapeutics, Inc. | Sina-zusammensetzungen |
| WO2014052563A2 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| MX363243B (es) | 2012-11-28 | 2019-03-14 | Merck Sharp & Dohme | Composiciones para tratar cáncer y usos de dichas composiciones. |
| BR112015013611A2 (pt) | 2012-12-20 | 2017-11-14 | Merck Sharp & Dohme | composto, e, composição farmacêutica |
| EP2951180B1 (de) | 2013-01-30 | 2018-05-02 | Merck Sharp & Dohme Corp. | 2,6,7,8-substituierte purine als hdm2-inhibitoren |
| EP3041938A1 (de) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Kreisförmige polynukleotide |
| US20170140680A1 (en) * | 2015-11-12 | 2017-05-18 | J. J. Keller & Associates, Inc. | Electronic placard |
| WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| WO2020019247A1 (en) * | 2018-07-26 | 2020-01-30 | Xw Laboratories, Inc. | Compounds as neurokinin-1 receptor antagonists and uses thereof |
| US20210277009A1 (en) | 2018-08-07 | 2021-09-09 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| WO2020033284A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS174885B2 (de) * | 1972-06-01 | 1977-04-29 | ||
| GB1574418A (en) * | 1976-11-16 | 1980-09-03 | Anphar Sa | Piperidine derivatives |
| WO1990005525A1 (en) * | 1988-11-23 | 1990-05-31 | Pfizer Inc. | Quinuclidine derivatives as substance p antagonists |
| US5232929A (en) * | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
| DK0532527T3 (da) * | 1990-06-01 | 1995-01-02 | Pfizer | 3-amino-2-arylquinuclidiner, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse |
| US5422354A (en) * | 1990-07-23 | 1995-06-06 | Pfizer Inc | Quinuclidine derivatives |
| CZ387492A3 (en) * | 1990-09-28 | 1994-02-16 | Pfizer | Analogs of non-aromatic hetero cycles containing nitrogen with a condensed ring, process of their preparation and use |
| DK0573522T3 (da) * | 1991-03-01 | 1995-03-06 | Pfizer | 1-Azabicyclo(3,2,2)nonan-3-aminderivater |
| HUT67276A (en) * | 1991-03-26 | 1995-03-28 | Pfizer | Stereoselective preparation of substituted piperidines |
| DK0585328T3 (da) * | 1991-05-22 | 2002-02-11 | Pfizer | Substituerede 3-aminoquinuclidiner |
| KR100214905B1 (ko) * | 1991-05-31 | 1999-08-02 | 디. 제이. 우드, 스피겔 알렌 제이 | 퀴누클리딘 유도체 |
| DE69213451T2 (de) * | 1991-06-20 | 1997-01-09 | Pfizer | Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen |
| TW202432B (de) * | 1991-06-21 | 1993-03-21 | Pfizer | |
| EP0536817A1 (de) * | 1991-07-05 | 1993-04-14 | MERCK SHARP & DOHME LTD. | Azabicyclische Verbindungen als Tachykinin-Antagonisten |
| DE69232588T2 (de) * | 1991-09-26 | 2002-08-22 | Pfizer | Kondensierte trizyklische, stickstoffenthaltende Verbindungen als Substanz P Rezeptor Antagonisten |
| HUT70741A (en) * | 1991-11-12 | 1995-10-30 | Pfizer | Acyclic ethylenediamine derivatives as substance p receptor antagonists |
-
1993
- 1993-05-05 CA CA002141048A patent/CA2141048C/en not_active Expired - Fee Related
- 1993-05-05 JP JP6506227A patent/JP2909214B2/ja not_active Expired - Fee Related
- 1993-05-05 EP EP93910925A patent/EP0655996B1/de not_active Expired - Lifetime
- 1993-05-05 AU AU42249/93A patent/AU4224993A/en not_active Abandoned
- 1993-05-05 PT PT93910925T patent/PT655996E/pt unknown
- 1993-05-05 WO PCT/US1993/004063 patent/WO1994004496A1/en active IP Right Grant
- 1993-05-05 AT AT93910925T patent/ATE208376T1/de not_active IP Right Cessation
- 1993-05-05 DE DE69331103T patent/DE69331103T2/de not_active Expired - Fee Related
- 1993-05-05 DK DK93910925T patent/DK0655996T3/da active
- 1993-05-05 EP EP01108881A patent/EP1114823A3/de not_active Withdrawn
- 1993-05-05 ES ES93910925T patent/ES2164072T3/es not_active Expired - Lifetime
- 1993-05-05 US US08/387,765 patent/US5721255A/en not_active Expired - Fee Related
- 1993-08-12 IL IL106670A patent/IL106670A0/xx unknown
- 1993-08-17 MX MX9304996A patent/MX9304996A/es unknown
- 1993-08-18 FI FI933641A patent/FI106552B/fi not_active IP Right Cessation
- 1993-08-18 HU HU9302372A patent/HU9302372D0/hu unknown
- 1993-08-18 CN CN93109599A patent/CN1088917A/zh active Pending
- 1993-08-23 SI SI9300443A patent/SI9300443A/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1114823A3 (de) | 2001-07-18 |
| MX9304996A (es) | 1994-05-31 |
| JP2909214B2 (ja) | 1999-06-23 |
| DE69331103D1 (de) | 2001-12-13 |
| AU4224993A (en) | 1994-03-15 |
| PT655996E (pt) | 2002-04-29 |
| IL106670A0 (en) | 1993-12-08 |
| JPH07508755A (ja) | 1995-09-28 |
| DE69331103T2 (de) | 2002-03-14 |
| FI106552B (fi) | 2001-02-28 |
| WO1994004496A1 (en) | 1994-03-03 |
| FI933641A0 (fi) | 1993-08-18 |
| FI933641A (fi) | 1994-02-20 |
| EP1114823A2 (de) | 2001-07-11 |
| EP0655996B1 (de) | 2001-11-07 |
| ES2164072T3 (es) | 2002-02-16 |
| US5721255A (en) | 1998-02-24 |
| CN1088917A (zh) | 1994-07-06 |
| CA2141048C (en) | 2003-03-18 |
| ATE208376T1 (de) | 2001-11-15 |
| DK0655996T3 (da) | 2001-12-27 |
| HU9302372D0 (en) | 1993-10-28 |
| CA2141048A1 (en) | 1994-03-03 |
| EP0655996A1 (de) | 1995-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI9300443A (en) | Substituted benzylamino nitrogen containing non-aromatic heterocycles | |
| US5703065A (en) | Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds | |
| EP0675886B1 (de) | Aminomethylen substituierte heterocyclische verbindungen und ihre verwendung alssubstanz p antagonisten | |
| TWI297270B (en) | Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors | |
| WO1994004496A9 (en) | Substituted benzylamino nitrogen containing non-aromatic heterocycles | |
| US6890936B2 (en) | Muscarinic antagonists | |
| JP2003525938A (ja) | ３−（ジアリールメチレン）−８−アザビシクロ［３．２．１］オクタン誘導体 | |
| PT101045A (pt) | Derivados de etilenodiamina aciclicos de compostos heterociclicos contendo azoto | |
| JP2007518740A (ja) | ムスカリン性アセチルコリン受容体アンタゴニスト | |
| AU2017202849C1 (en) | Potent and Selective Inhibitors of Monoamine Transporters; Method of Making; and Use Thereof | |
| EP2507225B1 (de) | L -dihydro-2-oxochinolinverbindungen als 5-ht4 rezeptorliganden | |
| JP2023503330A (ja) | カンナビノイド誘導体 | |
| US9932355B2 (en) | 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivatives and use thereof | |
| US20240043387A1 (en) | Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same | |
| US6372754B1 (en) | Spirocyclic ketones and their use as tachykinin antagonists | |
| TW201026691A (en) | Biaryl spiroaminooxazoline analogues as alpha2C adrenergic receptor modulators | |
| CA2171972C (en) | Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds | |
| KR20030036834A (ko) | 5-페닐벤질아민 화합물, 그의 제법 및 그의 합성 중간체 | |
| WO1995021168A1 (en) | Meso-azanoradamantanes | |
| NZ749473A (en) | Benzo-n-hydroxy amide compounds having antitumor activity |